Literature DB >> 33929591

C-reactive protein/albumin ratio as an indicator of disease activity in Behçet's disease and human leukocyte antigen-B27-associated uveitis.

Mirinae Kim1,2, Young-Gun Park1,2, Young-Hoon Park3,4.   

Abstract

PURPOSE: To explore the role of systemic inflammatory markers as indicators of acute exacerbation of chronic diseases and disease activity in uveitis.
METHODS: This study included 50 patients with Behçet's disease (BD)-associated uveitis and 52 patients with human leukocyte antigen-B27 (HLA-B27)-associated uveitis. Laboratory tests were conducted to measure complete blood count, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), CRP/albumin ratio (CAR), neutrophil to lymphocyte ratio (NLR), and platelet to lymphocyte ratio (PLR) during the uveitis phase and after resolution. The results measured during the two phases were assessed and compared.
RESULTS: The mean age of the participants was 41.4 ± 10.8 years; 68.6% of the patients were male. In both groups, ESR, CRP, and CAR were significantly higher during the uveitic phase (P < .001). However, the white blood cell count, albumin, NLR, and PLR measured during the uveitic phase and after resolution did not vary significantly (P > .05). ESR and CAR were correlated with the severity of intraocular inflammation. The area under the curve (AUC) of CAR, which was used to predict the presence of uveitis, was 0.801 (95% CI, 0.741-0.861); this value is strong compared with those of other inflammatory biomarkers.
CONCLUSIONS: CAR is correlated with the severity of intraocular inflammation in BD- and HLA-B27-associated uveitis. Furthermore, CAR appears to be a useful marker of disease activity for uveitis and is the most sensitive marker for discriminating the presence of acute uveitis in patients who have chronic uveitis as a symptom of BD- and HLA-B27-associated diseases.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Albumin; Behçet’s disease; C-reactive protein; C-reactive protein/albumin ratio; HLA-B27; Uveitis

Year:  2021        PMID: 33929591     DOI: 10.1007/s00417-021-05207-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  28 in total

1.  Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss.

Authors:  D C McMillan; W S Watson; P O'Gorman; T Preston; H R Scott; C S McArdle
Journal:  Nutr Cancer       Date:  2001       Impact factor: 2.900

2.  Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Authors:  F Haverkate; S G Thompson; S D Pyke; J R Gallimore; M B Pepys
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

3.  Assessment of Relationship Between C-Reactive Protein to Albumin Ratio and Coronary Artery Disease Severity in Patients With Acute Coronary Syndrome.

Authors:  Metin Çağdaş; Ibrahim Rencüzoğullari; Süleyman Karakoyun; Yavuz Karabağ; Mahmut Yesin; Inanç Artaç; Doğan Iliş; Öznur Sadioğlu Çağdaş; Aysu Hayriye Tezcan; Halil Ibrahim Tanboğa
Journal:  Angiology       Date:  2017-11-26       Impact factor: 3.619

Review 4.  Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis.

Authors:  Qian Wang; Junfen Ma; Zhiyun Jiang; Liang Ming
Journal:  Int Angiol       Date:  2017-05-24       Impact factor: 2.789

5.  Elevation of C-reactive protein in "active" coronary artery disease.

Authors:  B C Berk; W S Weintraub; R W Alexander
Journal:  Am J Cardiol       Date:  1990-01-15       Impact factor: 2.778

6.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

Authors:  G Liuzzo; L M Biasucci; J R Gallimore; R L Grillo; A G Rebuzzi; M B Pepys; A Maseri
Journal:  N Engl J Med       Date:  1994-08-18       Impact factor: 91.245

Review 7.  High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.

Authors:  Wolfgang Koenig
Journal:  Int J Cardiol       Date:  2013-08-24       Impact factor: 4.164

8.  The C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Patients with Severe Sepsis or Septic Shock Treated with Early Goal-Directed Therapy.

Authors:  Min Hyung Kim; Jin Young Ahn; Je Eun Song; Heun Choi; Hea Won Ann; Jae Kyoung Kim; Jung Ho Kim; Yong Duk Jeon; Sun Bean Kim; Su Jin Jeong; Nam Su Ku; Sang Hoon Han; Young Goo Song; Jun Young Choi; Young Sam Kim; June Myung Kim
Journal:  PLoS One       Date:  2015-07-09       Impact factor: 3.240

9.  Clinical usefulness of early serial measurements of C-reactive protein as outcome predictors in patients with subarachnoid hemorrhage.

Authors:  Sangkil Lee; Yong Oh Kim; Jeong-Am Ryu
Journal:  BMC Neurol       Date:  2020-03-27       Impact factor: 2.474

10.  Preoperative Neutrophil-to-Lymphocyte Ratio Was a Predictor of Overall Survival in Small Renal Cell Carcinoma: An Analysis of 384 Consecutive Patients.

Authors:  Hao Zhao; Wang Li; Xiang Le; Zixiang Li; Peng Ge
Journal:  Biomed Res Int       Date:  2020-03-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.